MedPath

Assessment of Lung Recruitablity of Acute Respiratory Distress Syndrome With SARS-CoV-2 Pneumonia by Electrical Impedance Tomography

Completed
Conditions
ARDS
Critical Illness
Registration Number
NCT04473300
Lead Sponsor
Osaka University
Brief Summary

Novel coronavirus (SARS-CoV-2: severe acute respiratory coronavirus 2) pneumonia often develop the acute respiratory distress syndrome (ARDS). Lung protective ventilation strategy consisting of low tidal volume and high positive end-expiratory pressure (PEEP) is recommended. However, it is not clear whether injured lungs from SARS-CoV-2 pneumonia have the same mechanical properties, especially response to PEEP as common ARDS. Therefore, the investigators propose an observational study to analyze respiratory mechanics and lung recruitablity using EIT (electrical impedance tomography) in patients with ARDS due to SARS-CoV-2 pneumonia.

Detailed Description

The multi-center prospective observational study will enroll 20 adult ARDS patients under mechanical ventilation from Intensive Care Units (ICUs) in Japan and Peru. Informed consent will be waived due to the nature of observational study. Patients with positive SARS-CoV-2 infection will be included. Prior to initiating the protocol, patients will be sedated deeply with sedatives and/or opioids and paralyzed with a continuous infusion of rocuronium. The distribution of ventilation will be evaluated with EIT.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
43
Inclusion Criteria
  1. Patients with positive SARS-CoV-2 infection*

  2. Patients with ARDS under mechanical ventilation**

  3. Patients ≧ 18 years old

    • Definition of SARS-CoV-2 infection positive: SARS-CoV-2 infection is defined as being positive in RT-PCR (real time reverse transcriptase-polymerase chain reaction) assay using nasal or pharyngeal swab samples.

      • Definition of ARDS is as per the Berlin definition (PaO2/FiO2 ≦ 300 mmHg with PEEP ≧ 5 cmH2O)
Exclusion Criteria
  1. Contraindication for EIT monitoring

    1. Unstable spine or pelvic fractures
    2. Pacemaker, automatic implantable cardioverter defibrillator
    3. Skin lesions between the 4th and 5th ribs where the EIT belt is worn
  2. Home mechanical ventilation before inclusion

  3. Pregnancy

  4. DNR (do-not-resuscitate)

  5. Increased intracranial pressure (> 18 mmHg)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The distribution of ventilationThrough study completion (up to 24 hours)

The distribution of ventilation measured by EIT at PEEP 5 and 15.

Secondary Outcome Measures
NameTimeMethod
Silent spacesThrough study completion (up to 24 hours)

The changes in dependent and non-dependent silent spaces measured by EIT in PEEP 5 and 15.

Respiratory system complianceThrough study completion (up to 24 hours)

Respiratory system compliance in PEEP 5 and 15.

OxygenationThrough study completion (up to 24 hours)

Oxygenation in PEEP 5 and 15.

Dead space ventilation ratioThrough study completion (up to 24 hours)

Dead space ventilation ratio in PEEP 5 and 15.

Trial Locations

Locations (1)

Osaka University Hospital

🇯🇵

Suita, Osaka, Japan

© Copyright 2025. All Rights Reserved by MedPath